Ditch the good, buy the bad and the ugly

Ben Inker | GMO | 5 February 2015


There has seldom seemed to be a much starker choice facing equity investors than there is today. On the one hand you have US stocks, where profits¹ have compounded at 11% for the past four years, real G...

Not yet a Member? It’s quick and free to join. Already a member? Please log in.